Cervical spondylotic radiculopathy Musculoskeletal Diseases
Conditions
Interventions
Patients are divided into the observation group and control group 1:1 with the help of a random number table.
Observation group:
Ultra-laser irradiation + gabapentin (oral capsules, starting dose 300
Sponsors
The First People's Hospital of Fuyang District, Hangzhou
Eligibility
Sex/Gender
All
Age
60 Years to 120 Years
Inclusion criteria
Inclusion criteria: 1. Diagnosed with cervical spondylotic radiculopathy according to Rehabilitation Guidelines for Diagnosis and Treatment of Cervical Spondylosis (2010) 2. Aged =60 years 3. No history of peripheral nerve disease 4. No severe systemic diseases (cardiovascular, respiratory, digestive, liver, kidney disorders) 5. No opioid, NSAID, antidepressant, or antiepileptic drug use in the past month 6. Willingness to participate and signed informed consent
Exclusion criteria
Exclusion criteria: 1. Severe osteoporosis or bone tuberculosis 2. Nerve-related disorders not caused by cervical spondylotic radiculopathy (e.g., thoracic outlet syndrome, carpal tunnel syndrome, scapulohumeral periarthritis) 3. Severe cardiovascular, cerebrovascular, hepatic, renal, or hematopoietic diseases 4. Poor treatment adherence or incomplete clinical data 5. Congenital musculoskeletal disorders (e.g., congenital torticollis, congenital myopathy)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain relief measured by the Numerical Rating Scale (NRS/NPRS) at baseline and after three courses of treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Health-related quality of life improvement assessed by EuroQol-five dimensions (EQ-5D) questionnaire at baseline and after treatment 2. Incidence of adverse reactions (gastrointestinal discomfort, dizziness, lethargy, edema, rash, ataxia, fatigue) recorded throughout the study | — |
Countries
China
Contacts
Public ContactZhou Yu
Outcome results
None listed